Eric Falcand

Part of Servier SAS, Servier CJSC is a Russian international pharmaceutical company that produces original medicines for the treatment of various diseases. The company is based in Rostov, Russian Federation. The company operates in 149 countries and has more than 20,000 employees. Servier is the second largest French pharmaceutical company in the world and manages by a non-profit foundation. The company's focus is on cardiovascular diseases, chronic venous diseases, oncology, diabetes mellitus, neuropsychiatric, and other diseases.

Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium.

Neopharmed Gentili SpA is a holding company, which engages in the production and sale of pharmaceutical products. the firm includes development and marketing of therapeutic solutions in vascular, cardio-metabolic, respiratory, antibiotic, and over-the-counter medications. Its products include drugs, medical devices, food supplements, and cosmetics. The company was founded in 2009 and is headquartered in Milan, Italy.

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.

Servier Monde SAS provides legal services. The company is headquartered in Suresnes, France.

Part of Baxter International, Inc., Servier IP UK Ltd. is a company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million.